Back to Search
Start Over
Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer.
- Source :
-
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2011 Oct; Vol. 74 (1), pp. 112-7. Date of Electronic Publication: 2011 Mar 12. - Publication Year :
- 2011
-
Abstract
- Purpose: This study investigated the preoperative serum levels of CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer.<br />Subjects: This study evaluated 341 patients who had undergone a complete resection for stage I NSCLC between 2002 and 2008.<br />Results: The patients included 193 males and 148 females. The mean age of the patients was 69.2 years (range: 19-88). The histological types included 264 adenocarcinomas, 56 squamous cell carcinomas, 11 large cell carcinomas, and 10 other types of carcinoma. A pneumonectomy was performed in 2 patients, a bilobectomy in 7, a lobectomy in 255, a segmentectomy in 46, and partial resection of the lung in 31 patients. The positive rates for CYFRA 21-1 in the adenocarcinoma and squamous cell carcinoma patients were 33.3% and 76.8%, respectively. The positive rates for CEA in adenocarcinoma and squamous cell carcinoma patients were 23.8% and 26.8%, respectively. The 5-year survival rate after surgery in the normal CYFRA 21-1 group and the high CYFRA 21-1 groups were 92.8% and 75.4%, respectively, in the patients with stage I NSCLC. There was a significant difference between the 2 groups (p<0.0001). The 5-year survival rate according to the serum level of CEA in the patients with stage I NSCLC were 88.3% for the normal group and 76.3% for the high group. In a multivariate analysis using the variables found to be significant prognostic factors in univariate analysis, a high CYFRA 21-1 level was found to be a significant independent prognostic factor (95% confidence interval 1.213-5.442, p=0.014).<br />Conclusion: A high preoperative CYFRA 21-1 level was a significant independent prognostic factor in patients with stage I NSCLC. The patients with a high CYFRA 21-1 level should carefully followed-up to rule out occult metastasis. Further clinical studies will be necessary to evaluate the efficacy of adjuvant therapy for the patients selected according to this criterion.<br /> (Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.)
- Subjects :
- Adult
Aged
Aged, 80 and over
Antigens, Neoplasm genetics
Carcinoma, Non-Small-Cell Lung mortality
Carcinoma, Non-Small-Cell Lung pathology
Carcinoma, Non-Small-Cell Lung physiopathology
Disease Progression
Female
Humans
Keratin-19 genetics
Lung Neoplasms mortality
Lung Neoplasms pathology
Lung Neoplasms physiopathology
Male
Middle Aged
Neoplasm Staging
Preoperative Care
Prognosis
Receptors, Cell Surface genetics
Survival Analysis
Antigens, Neoplasm metabolism
Biomarkers, Tumor metabolism
Carcinoma, Non-Small-Cell Lung diagnosis
Keratin-19 metabolism
Lung Neoplasms diagnosis
Receptors, Cell Surface metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1872-8332
- Volume :
- 74
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Lung cancer (Amsterdam, Netherlands)
- Publication Type :
- Academic Journal
- Accession number :
- 21397974
- Full Text :
- https://doi.org/10.1016/j.lungcan.2011.02.001